A phase II/III of Volasertib in patients with Acute-myeloid-leukaemia and other cancers
Latest Information Update: 25 Nov 2021
At a glance
- Drugs Volasertib (Primary)
- Indications Acute myeloid leukaemia; Cancer
- Focus Therapeutic Use
- 25 Nov 2021 New trial record